OKRA.ai announces extension of its collaboration with a leading healthcare company to leverage OKRA.ai commercial brain.
CAMBRIDGE, UK – 13 January 2022 – Empowering the pharma industry with AI
-
OKRA.ai has been working with Bristol Myers Squibb since 2018
-
OKRA.ai enables connectivity and interrogation of multiple data sets to support decision making
-
Further EU expansion opportunities in 2022
OKRA.ai, a leading provider of Artificial Intelligence (AI) driven analytics for global life sciences, today announced that it is extending its collaboration with Bristol Myers Squibb to leverage OKRA’s AI Technology to support future customer engagement. This collaboration, which started in the UK in 2018 has proven to be very successful in bringing together multiple data sources and generating intelligent insights for commercial teams whilst delivering unparalleled levels of automation for the company. In 2021 OKRA.ai and Bristol Myers Squibb expanded use of the system to new markets and will continue to work together and explore further expansion opportunities in 2022.
Loubna Bouarfa, CEO of OKRA.ai said, “We’re very excited to announce the work with Bristol Myers Squibb. We started in 2018 and have been continuously validating the benefit and accuracy of our insights with the team. This journey has seen us deploy a fully automated portal that uses vast amounts of data and not rules to support dynamic decision making across the commercial organisation”. “We continue to educate the industry on what it means to truly have an AI brain where automation, data pipelines, accuracy, explainability and transparency are fundamental to success and Bristol Myers Squibb have fully embraced this with us”.
As a company applying AI to all stages of the drug lifecycle: market access, medical and commercial, and with the pharmaceutical industry under unprecedented pressure to deliver value at speed, high quality, explainable AI has become an essential companion for busy professionals.
About OKRA Technologies
OKRA founded in 2015, is a technology company transforming life sciences with Artificial Intelligence solutions. The company combines advanced AI with a hybrid explainability engine to drive commercial, medical, clinical and market access outcomes in life sciences. The company has developed the ‘OKRA Engine’, a leading AI Engine that is driving predictions, suggestions and reasons in real time to empower users to make smarter decisions with evidence based outputs. OKRA Technologies is headquartered in Cambridge (UK) with an additional office in Leiden (Netherlands).
To find out more about OKRA or request a demo click here.
